The cannabinoids have a long history as drugs of abuse, with profound effects at neurochemical, physiological and behavioral levels. Nevertheless, the molecular mechanisms of action of these drugs are still unknown. An important breakthrough in this field occurred with the discovery that Lambda 9-tetrahydrocannabinol (THC) and its analogs bind to brain membrane receptors which are coupled to G-proteins to inhibit adenylyl cyclase. While these THC receptors are probably not responsible for all CNS actions of cannabinoids, they may help explain some specific neuronal actions of these compounds. Moreover, since many other neurotransmitters and neuromodulators bind to G-protein-coupled receptors, these results suggest that cannabinoids may not simply be exogenous drugs of abuse but also be members of a novel class of neurotransmitters. The current study will explore components of the putative endogenous cannabinoid system in the brain by utilizing a novel class of compounds, the aminoalkylindoles (AAIs). The AAIs, originally synthesized as analgesics, are now known to bind to the same G-protein-coupled receptors as THC. These receptors can be studied by radioreceptor and cerebellar granule cells, and by inhibition of electrically-induced contractions of mouse vas deferens. Moreover, the AAIs contain a series of antagonists which competitively antagonize these receptor actions of THC. These compounds may be the first specific THC antagonists to be reported. This project will focus on THC and AAI actions in cultured cerebellar granule cells, which represent a novel, non-transformed cell culture system for the study of cannabinoid receptors. Other experiments will utilize these different methods of receptor assay, combined with specific AAI/THC antagonists, to isolate endogenous ligands binding to these receptor sites.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA006784-02
Application #
3213497
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1991-04-01
Project End
1994-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Vardanyan, Ruben; Vijay, Gokhale; Nichol, Gary S et al. (2009) Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain. Bioorg Med Chem 17:5044-53
Childers, Steven R (2006) Activation of G-proteins in brain by endogenous and exogenous cannabinoids. AAPS J 8:E112-7
Howlett, Allyn C; Breivogel, Christopher S; Childers, Steven R et al. (2004) Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47 Suppl 1:345-58
Breivogel, Christopher S; Walker, J Michael; Huang, Susan M et al. (2004) Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids. Neuropharmacology 47:81-91
Sim-Selley, Laura J; Vogt, Leslie J; Vogt, Brent A et al. (2002) Cellular localization of cannabinoid receptors and activated G-proteins in rat anterior cingulate cortex. Life Sci 71:2217-26
Sim-Selley, Laura J; Childers, Steven R (2002) Neuroanatomical localization of receptor-activated G proteins in brain. Methods Enzymol 344:42-58
Prather, P L; Martin, N A; Breivogel, C S et al. (2000) Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies. Mol Pharmacol 57:1000-10
Breivogel, C S; Childers, S R (2000) Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition. J Pharmacol Exp Ther 295:328-36
Breivogel, C S; Childers, S R; Deadwyler, S A et al. (1999) Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem 73:2447-59
Childers, S R; Breivogel, C S (1998) Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend 51:173-87

Showing the most recent 10 out of 24 publications